Insulin Resistance is Associated with Gut Permeability Without the Direct Influence of Obesity in Young Adults

References

• Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Nm J Clin Invest. 2016;126(1):12–22. doi:10.1172/JCI77812
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Rodelo C, Roura-Guiberna A, Olivares-Reyes JA. Molecular mechanisms of insulin resistance: an update. Gac Med Mex. 2017;153:197–209.
   Google Scholar
• Eltom MA, Ahmed MH. Increasing prevalence of type diabetes mellitus of ethnicity in Northern Sudan. Diabetes Res Clin Pract. 2018;136:93–99. doi:10.1016/j.diabres.2017.11.034
   PubMedGoogle Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Int Diabetes Fed; 2015. Available from:: http://www.idf.org/diabetesatlas. Accessed January 2, 2016.
   Google Scholar
• SEMDSA Type 2 Diabetes Guidelines Expert Committee. The 2017 SEMDSA guideline for the management of type 2 diabetes. JEMDSA. 2017;22(1):S1–S196.
   Google Scholar
• Wu Y, Ding Y, Tanaka Y, Zhang W. Review risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–1200. doi:10.7150/ijms.10001
   PubMed Web of Science ®Google Scholar
• Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue an endocrine gland. Arch Med Sci. 2013;9(2):191–200. doi:10.5114/aoms.2013.33181
   PubMed Web of Science ®Google Scholar
• Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640. doi:10.3389/fphys.2018.00640
   PubMed Web of Science ®Google Scholar
• Facey A 1, Dilworth L, Irving R. A review of the leptin hormone and the association with obesity and diabetes mellitus. J Diabetes Metab. 2017;8:3. doi:10.4172/2155-6156.100072
   Google Scholar
• Gariballa S, Alkaabi J, Yasin J, Al Essa A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord. 2019;19(1):55. doi:10.1186/s12902-019-0386-z
   PubMedGoogle Scholar
• Rudnicki M, Abdifarkosh G, Rezvan O, Nwadozi E, Roudier E, Haas TL. Female mice have higher angiogenesis in perigonadal adipose tissue than males in response to high-fat diet. Front Physiol. 2018;9:1452. doi:10.3389/fphys.2018.01452
   PubMed Web of Science ®Google Scholar
• Martins LM, Oliveira ARS, Cruz KJC, Torres-Leal FL, Marreiro DN. Obesity, inflammation, and insulin resistance. Braz J Pharm Sci. 2014;50(4):677–685. doi:10.1590/S1984-82502014000400003
   Web of Science ®Google Scholar
• Kang YE, Kim JM, Joung KH, et al. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS One. 2016;11:4.
   Google Scholar
• Torres-Leal FL, Fonseca-Alaniz MH, Rogero MM, Tirapegui J. The role of inflamed adipose tissue in the insulin resistance. Cell Biochem Funct. 2010;28(8):623–631. doi:10.1002/cbf.1706
   PubMedGoogle Scholar
• Finucane FM, Luan J, Wareham NJ, et al. Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia. 2009;52(11):2345–2349. doi:10.1007/s00125-009-1508-3
   PubMed Web of Science ®Google Scholar
• Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100–109. doi:10.1016/j.cyto.2016.06.028
   PubMed Web of Science ®Google Scholar
• Saad MJA, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31(4):283–293. doi:10.1152/physiol.00041.2015
   PubMed Web of Science ®Google Scholar
• Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr. 2012;35:14–20. doi:10.1177/0148607111413772
   Google Scholar
• Amar J, Chabo C, Waget A, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011;3:559–572. doi:10.1002/emmm.201100159
   PubMed Web of Science ®Google Scholar
• Teixeira TDS, Collado MC, Ferreira CLLF, Bressan J, Peluzio MCG. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nut Res. 2012;32:637–647. doi:10.1016/j.nutres.2012.07.003
   PubMed Web of Science ®Google Scholar
• Damms-Machado A, Louis S, Schnitzer A, et al. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am J Clin Nutr. 2017;105(1):127–135. doi:10.3945/ajcn.116.131110
   PubMed Web of Science ®Google Scholar
• Jung U, Choi M. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and non-alcoholic fatty liver disease. Int J Mol Sci. 2014;215:6184–6223. doi:10.3390/ijms15046184
   Google Scholar
• Refaie MR, Sayed-Ahmed NA, Bakr AM, Abdel Aziz MY, Abdel-Gawad SS, Kannishi MH. Aging is an inevitable risk factor for insulin resistance. J Taibah Univ Sci. 2006;1(1):30–41. doi:10.1016/S1658-3612(06)70005-1
   Google Scholar
• Karakelides H, Irving BA, Short KR, O’Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 2010;59(1):89–97. doi:10.2337/db09-0591
   PubMed Web of Science ®Google Scholar
• Stewart A, Marfell-Jones M, Olds T, Ridder H. International Standards for Anthropometric Assessment. Lower Hutt: ISAK; 2011.
   Google Scholar
• Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut‐offs for thinness, overweight and obesity. Pediatr Obes. 2012;7(12):284–294.
   PubMedGoogle Scholar
• Anhê FF, Roy D, Pilon G, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64(6):872–883. doi:10.1136/gutjnl-2014-307142
   PubMed Web of Science ®Google Scholar
• Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11(10):577. doi:10.1038/nrendo.2015.128
   PubMed Web of Science ®Google Scholar
• Belkina AC, Denis GV. Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):472–477. doi:10.1097/MED.0b013e32833c5c48
   PubMedGoogle Scholar
• Rossouw HA, Grant CC, Viljoen M. Overweight and obesity in children and adolescents: the South African problem. S Afr J Sci. 2012;108(5/6):31–37. doi:10.4102/sajs.v108i5/6.907
   Google Scholar
• Lee YS, Osborne O, Youngoh D, et al. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339–1352. doi:10.1016/j.cell.2014.05.012
   PubMed Web of Science ®Google Scholar
• Forny-Germano L, De Felice FG, Vieira MN. The role of leptin and adiponectin in obesity-associated cognitive decline and alzheimer’s disease. Front Neurosci. 2019;12:1027. doi:10.3389/fnins.2018.01027
   PubMedGoogle Scholar
• Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54. doi:10.1172/JCI88880
   PubMed Web of Science ®Google Scholar
• Wensveen FM, Jelenčić V, Valentić S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16(4):376. doi:10.1038/ni.3120
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
   PubMed Web of Science ®Google Scholar
• Singh Y, Garg MK, Tandon N, Marwaha RK. A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol. 2013;5(4):245–251. doi:10.4274/Jcrpe.1127
   PubMed Web of Science ®Google Scholar
• Johnson W. Healthy obesity: time to give up the ghost? Ann Hum Biol. 2018;45(4):297–298. doi:10.1080/03014460.2018.1444789
   PubMed Web of Science ®Google Scholar
• Calori G, Lattuada G, Piemonti L. Prevalence, metabolic features and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2011;34(1):210–215. doi:10.2337/dc10-0665
   PubMed Web of Science ®Google Scholar
• Stefan N, Kantartzis K, Machann J. Identification and characterization of metabolically begin obesity in humans. Arch Intern Med. 2008;168:1609–1616. doi:10.1001/archinte.168.15.1609
   PubMed Web of Science ®Google Scholar
• Moreno-Navarete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012;7:e37160. doi:10.1371/journal.pone.0037160
   PubMedGoogle Scholar
• Salvo-Romero E, Alonso-Cotoner C, Pardo-Camacho C, Casado-Bedmar M, Vicario M. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig. 2015;107:686–696. doi:10.17235/reed.2015.3846/2015
   PubMed Web of Science ®Google Scholar
• Winer DA, Luck H, Tsai S, Winer S. The intestinal immune system in obesity and insulin resistance. Cell Metab. 2016;23(3):413–426. doi:10.1016/j.cmet.2016.01.003
   PubMed Web of Science ®Google Scholar
• Ohlsson B, Orho-Melander M, Nilsson P. Higher levels of serum zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations. Int J Mol Sci. 2017;18(3):582. doi:10.3390/ijms18030582
   PubMedGoogle Scholar
• Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384. doi:10.1080/21688370.2016.1251384
   PubMed Web of Science ®Google Scholar